Abstract:Over the past few years, many machine learning-based scoring functions for predicting the binding of small molecules to proteins have been developed. Their objective is to approximate the distribution which takes two molecules as input and outputs the energy of their interaction. Only a scoring function that accounts for the interatomic interactions involved in binding can accurately predict binding affinity on unseen molecules. However, many scoring functions make predictions based on data set biases rather than an understanding of the physics of binding. These scoring functions perform well when tested on similar targets to those in the training set but fail to generalize to dissimilar targets. To test what a machine learning-based scoring function has learned, input attribution, a technique for learning which features are important to a model when making a prediction on a particular data point, can be applied. If a model successfully learns something beyond data set biases, attribution should give insight into the important binding interactions that are taking place. We built a machine learning-based scoring function that aimed to avoid the influence of bias via thorough train and test data set filtering and show that it achieves comparable performance on the Comparative Assessment of Scoring Functions, 2016 (CASF-2016) benchmark to other leading methods. We then use the CASF-2016 test set to perform attribution and find that the bonds identified as important by PointVS, unlike those extracted from other scoring functions, have a high correlation with those found by a distance-based interaction profiler. We then show that attribution can be used to extract important binding pharmacophores from a given protein target when supplied with a number of bound structures. We use this information to perform fragment elaboration and see improvements in docking scores compared to using structural information from a traditional, data-based approach. This not only provides definitive proof that the scoring function has learned to identify some important binding interactions but also constitutes the first deep learning-based method for extracting structural information from a target for molecule design.

Recent progress on the prospective application of machine learning to structure-based virtual screening

A Case-Based Meta-Learning Algorithm Boosts the Performance of Structure-Based Virtual Screening.

Improving Structure-Based Virtual Screening with Ensemble Docking and Machine Learning

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

Deep Learning in Virtual Screening: Recent Applications and Developments

Accuracy or novelty: what can we gain from target-specific machine-learning-based scoring functions in virtual screening?

Improving Structure-Based Virtual Screening Performance Via Learning from Scoring Function Components

Advances in machine intelligence-driven virtual screening approaches for big-data

Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances

Beware of the Generic Machine Learning-Based Scoring Functions in Structure-Based Virtual Screening.

Combined Usage of Ligand- and Structure-based Virtual Screening in the Artificial Intelligence Era

Computational representations of protein–ligand interfaces for structure-based virtual screening

Recent Developments in Structure-Based Virtual Screening Approaches

vScreenML v2.0: Improved Machine Learning Classification for Reducing False Positives in Structure-Based Virtual Screening

Combined strategies in structure-based virtual screening

Traditional and Machine Learning Approaches in Structure-Based Drug Virtual Screening

Consensus holistic virtual screening for drug discovery: a novel machine learning model approach

Assessment of the Generalization Abilities of Machine-Learning Scoring Functions for Structure-Based Virtual Screening

Machine Learning-based Virtual Screening and Its Applications to Alzheimer's Drug Discovery: A Review.

Target-Specific Machine Learning Scoring Function Improved Structure-Based Virtual Screening Performance for SARS-CoV-2 Drugs Development

A Small Step Toward Generalizability: Training a Machine Learning Scoring Function for Structure-Based Virtual Screening